2024 – 2026
M&A Separations & Carve‑outs
4 carve‑outs · 150+ applications · multi‑site, multi‑country
Global pharma group · TSA, minimal‑TSA and no‑TSA · regulated multi‑entity
Below budget
IT separation delivered with zero business disruption
~⅔
shorter delivery path through early scope arbitration
5-figure
monthly cost avoidance through early execution decisions